RecruitingNCT06987825

Chinese Atrial Fibrillation Registry


Sponsor

Beijing Anzhen Hospital

Enrollment

100,000 participants

Start Date

Aug 1, 2011

Study Type

OBSERVATIONAL

Conditions

Summary

This prospective, observational cohort study aims to establish a long-term registry of adult patients with atrial fibrillation (AF) in China to comprehensively characterize patient profiles and evaluate real-world management and outcomes over time. The objectives of the study are to: * Describe the demographic, clinical, and treatment characteristics of AF patients across different stages of disease progression. * Assess the effectiveness and safety of various AF treatment strategies, including oral anticoagulation, catheter ablation, and left atrial appendage closure, in routine clinical practice. * Identify patient- and treatment-related factors that influence therapeutic outcomes. * Explore the role of advanced technologies and artificial intelligence in improving procedural performance, risk stratification, and clinical decision-making in AF care. Participants will undergo standardized baseline evaluation and longitudinal follow-up to collect data on heart rhythm monitoring, treatment exposures, healthcare utilization, clinical events, and patient-reported outcomes. This cohort will generate real-world evidence to inform personalized and evidence-based management of AF.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This is a large registry study in China that is tracking people with atrial fibrillation (an irregular heartbeat) over time to better understand patterns of care, treatment choices, and long-term outcomes in real-world settings. **You may be eligible if...** - You are 18 or older - You have had a documented episode of atrial fibrillation lasting more than 30 seconds, confirmed by an ECG, Holter monitor, implantable cardiac monitor, or wearable heart device - You are willing to participate in follow-up visits **You may NOT be eligible if...** - Your atrial fibrillation was caused by a temporary or reversible condition - You have a condition that means your life expectancy is less than 1 year Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(2)

Beijing Anzhen Hospital

Beijing, Beijing Municipality, China

Sir Run Run Shaw Hospital, Zhejiang University School of Medicine

Hangzhou, Zhejiang, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06987825


Related Trials